 | • レポートコード：QYR2104Z2996 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、過眠症治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（モダフィニル、Xyrem、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・過眠症治療薬の市場動向 ・企業の競争状況、市場シェア ・過眠症治療薬の種類別市場規模（モダフィニル、Xyrem、その他） ・過眠症治療薬の用途別市場規模（病院薬局、小売薬局、オンライン薬局） ・過眠症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・過眠症治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・過眠症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・過眠症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・過眠症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Teva、Jazz Pharmaceuticals、BIOPROJET、AVADEL PHARMACEUTICALS、GlaxoSmithKline、Pfizer、Theranexus、Fisher & Paykel Healthcare、Drive Medical、Merck） ・結論 |
Hypersomnia indicates frequent and excessive daytime sleepiness. It becomes necessary for patients suffering from hypersomnia to take short naps in-between the day time and sleep more than 10 hours at night. However, the naps do not provide any relief. Also, patients may feel disoriented and can have difficulty in moving. Due to hypersomnia patients may have restlessness, loss of appetite hallucinations and slow speech.
Market Analysis and Insights: Global Hypersomnia Drug Market
The global Hypersomnia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hypersomnia Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hypersomnia Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hypersomnia Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hypersomnia Drug market.
Global Hypersomnia Drug Scope and Market Size
Hypersomnia Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hypersomnia Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Provigil
Xyrem
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Teva
Jazz Pharmaceuticals
BIOPROJET
AVADEL PHARMACEUTICALS
GlaxoSmithKline
Pfizer
Theranexus
Fisher & Paykel Healthcare
Drive Medical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hypersomnia Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Provigil
1.2.3 Xyrem
1.2.4 Others
1.3 Market by Application
1.3.1 Global Hypersomnia Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hypersomnia Drug Market Perspective (2016-2027)
2.2 Hypersomnia Drug Growth Trends by Regions
2.2.1 Hypersomnia Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hypersomnia Drug Historic Market Share by Regions (2016-2021)
2.2.3 Hypersomnia Drug Forecasted Market Size by Regions (2022-2027)
2.3 Hypersomnia Drug Industry Dynamic
2.3.1 Hypersomnia Drug Market Trends
2.3.2 Hypersomnia Drug Market Drivers
2.3.3 Hypersomnia Drug Market Challenges
2.3.4 Hypersomnia Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hypersomnia Drug Players by Revenue
3.1.1 Global Top Hypersomnia Drug Players by Revenue (2016-2021)
3.1.2 Global Hypersomnia Drug Revenue Market Share by Players (2016-2021)
3.2 Global Hypersomnia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hypersomnia Drug Revenue
3.4 Global Hypersomnia Drug Market Concentration Ratio
3.4.1 Global Hypersomnia Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hypersomnia Drug Revenue in 2020
3.5 Hypersomnia Drug Key Players Head office and Area Served
3.6 Key Players Hypersomnia Drug Product Solution and Service
3.7 Date of Enter into Hypersomnia Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hypersomnia Drug Breakdown Data by Type
4.1 Global Hypersomnia Drug Historic Market Size by Type (2016-2021)
4.2 Global Hypersomnia Drug Forecasted Market Size by Type (2022-2027)
5 Hypersomnia Drug Breakdown Data by Application
5.1 Global Hypersomnia Drug Historic Market Size by Application (2016-2021)
5.2 Global Hypersomnia Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Hypersomnia Drug Market Size (2016-2027)
6.2 North America Hypersomnia Drug Market Size by Type
6.2.1 North America Hypersomnia Drug Market Size by Type (2016-2021)
6.2.2 North America Hypersomnia Drug Market Size by Type (2022-2027)
6.2.3 North America Hypersomnia Drug Market Size by Type (2016-2027)
6.3 North America Hypersomnia Drug Market Size by Application
6.3.1 North America Hypersomnia Drug Market Size by Application (2016-2021)
6.3.2 North America Hypersomnia Drug Market Size by Application (2022-2027)
6.3.3 North America Hypersomnia Drug Market Size by Application (2016-2027)
6.4 North America Hypersomnia Drug Market Size by Country
6.4.1 North America Hypersomnia Drug Market Size by Country (2016-2021)
6.4.2 North America Hypersomnia Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Hypersomnia Drug Market Size (2016-2027)
7.2 Europe Hypersomnia Drug Market Size by Type
7.2.1 Europe Hypersomnia Drug Market Size by Type (2016-2021)
7.2.2 Europe Hypersomnia Drug Market Size by Type (2022-2027)
7.2.3 Europe Hypersomnia Drug Market Size by Type (2016-2027)
7.3 Europe Hypersomnia Drug Market Size by Application
7.3.1 Europe Hypersomnia Drug Market Size by Application (2016-2021)
7.3.2 Europe Hypersomnia Drug Market Size by Application (2022-2027)
7.3.3 Europe Hypersomnia Drug Market Size by Application (2016-2027)
7.4 Europe Hypersomnia Drug Market Size by Country
7.4.1 Europe Hypersomnia Drug Market Size by Country (2016-2021)
7.4.2 Europe Hypersomnia Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Hypersomnia Drug Market Size (2016-2027)
8.2 Asia-Pacific Hypersomnia Drug Market Size by Type
8.2.1 Asia-Pacific Hypersomnia Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hypersomnia Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hypersomnia Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Hypersomnia Drug Market Size by Application
8.3.1 Asia-Pacific Hypersomnia Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hypersomnia Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hypersomnia Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Hypersomnia Drug Market Size by Region
8.4.1 Asia-Pacific Hypersomnia Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hypersomnia Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hypersomnia Drug Market Size (2016-2027)
9.2 Latin America Hypersomnia Drug Market Size by Type
9.2.1 Latin America Hypersomnia Drug Market Size by Type (2016-2021)
9.2.2 Latin America Hypersomnia Drug Market Size by Type (2022-2027)
9.2.3 Latin America Hypersomnia Drug Market Size by Type (2016-2027)
9.3 Latin America Hypersomnia Drug Market Size by Application
9.3.1 Latin America Hypersomnia Drug Market Size by Application (2016-2021)
9.3.2 Latin America Hypersomnia Drug Market Size by Application (2022-2027)
9.3.3 Latin America Hypersomnia Drug Market Size by Application (2016-2027)
9.4 Latin America Hypersomnia Drug Market Size by Country
9.4.1 Latin America Hypersomnia Drug Market Size by Country (2016-2021)
9.4.2 Latin America Hypersomnia Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hypersomnia Drug Market Size (2016-2027)
10.2 Middle East & Africa Hypersomnia Drug Market Size by Type
10.2.1 Middle East & Africa Hypersomnia Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hypersomnia Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hypersomnia Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Hypersomnia Drug Market Size by Application
10.3.1 Middle East & Africa Hypersomnia Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hypersomnia Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hypersomnia Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Hypersomnia Drug Market Size by Country
10.4.1 Middle East & Africa Hypersomnia Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hypersomnia Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Hypersomnia Drug Introduction
11.1.4 Teva Revenue in Hypersomnia Drug Business (2016-2021)
11.1.5 Teva Recent Development
11.2 Jazz Pharmaceuticals
11.2.1 Jazz Pharmaceuticals Company Details
11.2.2 Jazz Pharmaceuticals Business Overview
11.2.3 Jazz Pharmaceuticals Hypersomnia Drug Introduction
11.2.4 Jazz Pharmaceuticals Revenue in Hypersomnia Drug Business (2016-2021)
11.2.5 Jazz Pharmaceuticals Recent Development
11.3 BIOPROJET
11.3.1 BIOPROJET Company Details
11.3.2 BIOPROJET Business Overview
11.3.3 BIOPROJET Hypersomnia Drug Introduction
11.3.4 BIOPROJET Revenue in Hypersomnia Drug Business (2016-2021)
11.3.5 BIOPROJET Recent Development
11.4 AVADEL PHARMACEUTICALS
11.4.1 AVADEL PHARMACEUTICALS Company Details
11.4.2 AVADEL PHARMACEUTICALS Business Overview
11.4.3 AVADEL PHARMACEUTICALS Hypersomnia Drug Introduction
11.4.4 AVADEL PHARMACEUTICALS Revenue in Hypersomnia Drug Business (2016-2021)
11.4.5 AVADEL PHARMACEUTICALS Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Hypersomnia Drug Introduction
11.5.4 GlaxoSmithKline Revenue in Hypersomnia Drug Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Hypersomnia Drug Introduction
11.6.4 Pfizer Revenue in Hypersomnia Drug Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Theranexus
11.7.1 Theranexus Company Details
11.7.2 Theranexus Business Overview
11.7.3 Theranexus Hypersomnia Drug Introduction
11.7.4 Theranexus Revenue in Hypersomnia Drug Business (2016-2021)
11.7.5 Theranexus Recent Development
11.8 Fisher & Paykel Healthcare
11.8.1 Fisher & Paykel Healthcare Company Details
11.8.2 Fisher & Paykel Healthcare Business Overview
11.8.3 Fisher & Paykel Healthcare Hypersomnia Drug Introduction
11.8.4 Fisher & Paykel Healthcare Revenue in Hypersomnia Drug Business (2016-2021)
11.8.5 Fisher & Paykel Healthcare Recent Development
11.9 Drive Medical
11.9.1 Drive Medical Company Details
11.9.2 Drive Medical Business Overview
11.9.3 Drive Medical Hypersomnia Drug Introduction
11.9.4 Drive Medical Revenue in Hypersomnia Drug Business (2016-2021)
11.9.5 Drive Medical Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Hypersomnia Drug Introduction
11.10.4 Merck Revenue in Hypersomnia Drug Business (2016-2021)
11.10.5 Merck Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Hypersomnia Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Provigil
Table 3. Key Players of Xyrem
Table 4. Key Players of Others
Table 5. Global Hypersomnia Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hypersomnia Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Hypersomnia Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Hypersomnia Drug Market Share by Regions (2016-2021)
Table 9. Global Hypersomnia Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Hypersomnia Drug Market Share by Regions (2022-2027)
Table 11. Hypersomnia Drug Market Trends
Table 12. Hypersomnia Drug Market Drivers
Table 13. Hypersomnia Drug Market Challenges
Table 14. Hypersomnia Drug Market Restraints
Table 15. Global Hypersomnia Drug Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Hypersomnia Drug Market Share by Players (2016-2021)
Table 17. Global Top Hypersomnia Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypersomnia Drug as of 2020)
Table 18. Ranking of Global Top Hypersomnia Drug Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Hypersomnia Drug Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hypersomnia Drug Product Solution and Service
Table 22. Date of Enter into Hypersomnia Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hypersomnia Drug Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Hypersomnia Drug Revenue Market Share by Type (2016-2021)
Table 26. Global Hypersomnia Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Hypersomnia Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Hypersomnia Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Hypersomnia Drug Revenue Market Share by Application (2016-2021)
Table 30. Global Hypersomnia Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Hypersomnia Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Hypersomnia Drug Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Hypersomnia Drug Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Hypersomnia Drug Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Hypersomnia Drug Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Hypersomnia Drug Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Hypersomnia Drug Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Hypersomnia Drug Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Hypersomnia Drug Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Hypersomnia Drug Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Hypersomnia Drug Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Hypersomnia Drug Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Hypersomnia Drug Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Hypersomnia Drug Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Hypersomnia Drug Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hypersomnia Drug Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hypersomnia Drug Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hypersomnia Drug Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Hypersomnia Drug Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Hypersomnia Drug Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Hypersomnia Drug Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Hypersomnia Drug Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Hypersomnia Drug Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Hypersomnia Drug Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Hypersomnia Drug Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Hypersomnia Drug Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Hypersomnia Drug Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hypersomnia Drug Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hypersomnia Drug Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hypersomnia Drug Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Hypersomnia Drug Market Size by Country (2022-2027) & (US$ Million)
Table 62. Teva Company Details
Table 63. Teva Business Overview
Table 64. Teva Hypersomnia Drug Product
Table 65. Teva Revenue in Hypersomnia Drug Business (2016-2021) & (US$ Million)
Table 66. Teva Recent Development
Table 67. Jazz Pharmaceuticals Company Details
Table 68. Jazz Pharmaceuticals Business Overview
Table 69. Jazz Pharmaceuticals Hypersomnia Drug Product
Table 70. Jazz Pharmaceuticals Revenue in Hypersomnia Drug Business (2016-2021) & (US$ Million)
Table 71. Jazz Pharmaceuticals Recent Development
Table 72. BIOPROJET Company Details
Table 73. BIOPROJET Business Overview
Table 74. BIOPROJET Hypersomnia Drug Product
Table 75. BIOPROJET Revenue in Hypersomnia Drug Business (2016-2021) & (US$ Million)
Table 76. BIOPROJET Recent Development
Table 77. AVADEL PHARMACEUTICALS Company Details
Table 78. AVADEL PHARMACEUTICALS Business Overview
Table 79. AVADEL PHARMACEUTICALS Hypersomnia Drug Product
Table 80. AVADEL PHARMACEUTICALS Revenue in Hypersomnia Drug Business (2016-2021) & (US$ Million)
Table 81. AVADEL PHARMACEUTICALS Recent Development
Table 82. GlaxoSmithKline Company Details
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Hypersomnia Drug Product
Table 85. GlaxoSmithKline Revenue in Hypersomnia Drug Business (2016-2021) & (US$ Million)
Table 86. GlaxoSmithKline Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Hypersomnia Drug Product
Table 90. Pfizer Revenue in Hypersomnia Drug Business (2016-2021) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Theranexus Company Details
Table 93. Theranexus Business Overview
Table 94. Theranexus Hypersomnia Drug Product
Table 95. Theranexus Revenue in Hypersomnia Drug Business (2016-2021) & (US$ Million)
Table 96. Theranexus Recent Development
Table 97. Fisher & Paykel Healthcare Company Details
Table 98. Fisher & Paykel Healthcare Business Overview
Table 99. Fisher & Paykel Healthcare Revenue in Hypersomnia Drug Business (2016-2021) & (US$ Million)
Table 100. Fisher & Paykel Healthcare Recent Development
Table 101. Drive Medical Company Details
Table 102. Drive Medical Business Overview
Table 103. Drive Medical Hypersomnia Drug Product
Table 104. Drive Medical Revenue in Hypersomnia Drug Business (2016-2021) & (US$ Million)
Table 105. Drive Medical Recent Development
Table 106. Merck Company Details
Table 107. Merck Business Overview
Table 108. Merck Hypersomnia Drug Product
Table 109. Merck Revenue in Hypersomnia Drug Business (2016-2021) & (US$ Million)
Table 110. Merck Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hypersomnia Drug Market Share by Type: 2020 VS 2027
Figure 2. Provigil Features
Figure 3. Xyrem Features
Figure 4. Others Features
Figure 5. Global Hypersomnia Drug Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Hypersomnia Drug Report Years Considered
Figure 10. Global Hypersomnia Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Hypersomnia Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Hypersomnia Drug Market Share by Regions: 2020 VS 2027
Figure 13. Global Hypersomnia Drug Market Share by Regions (2022-2027)
Figure 14. Global Hypersomnia Drug Market Share by Players in 2020
Figure 15. Global Top Hypersomnia Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypersomnia Drug as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Hypersomnia Drug Revenue in 2020
Figure 17. Global Hypersomnia Drug Revenue Market Share by Type (2016-2021)
Figure 18. Global Hypersomnia Drug Revenue Market Share by Type (2022-2027)
Figure 19. North America Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Hypersomnia Drug Market Share by Type (2016-2027)
Figure 21. North America Hypersomnia Drug Market Share by Application (2016-2027)
Figure 22. North America Hypersomnia Drug Market Share by Country (2016-2027)
Figure 23. United States Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Hypersomnia Drug Market Share by Type (2016-2027)
Figure 27. Europe Hypersomnia Drug Market Share by Application (2016-2027)
Figure 28. Europe Hypersomnia Drug Market Share by Country (2016-2027)
Figure 29. Germany Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Hypersomnia Drug Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Hypersomnia Drug Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Hypersomnia Drug Market Share by Region (2016-2027)
Figure 39. China Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Hypersomnia Drug Market Share by Type (2016-2027)
Figure 47. Latin America Hypersomnia Drug Market Share by Application (2016-2027)
Figure 48. Latin America Hypersomnia Drug Market Share by Country (2016-2027)
Figure 49. Mexico Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Hypersomnia Drug Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Hypersomnia Drug Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Hypersomnia Drug Market Share by Country (2016-2027)
Figure 55. Turkey Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Hypersomnia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Teva Revenue Growth Rate in Hypersomnia Drug Business (2016-2021)
Figure 59. Jazz Pharmaceuticals Revenue Growth Rate in Hypersomnia Drug Business (2016-2021)
Figure 60. BIOPROJET Revenue Growth Rate in Hypersomnia Drug Business (2016-2021)
Figure 61. AVADEL PHARMACEUTICALS Revenue Growth Rate in Hypersomnia Drug Business (2016-2021)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Hypersomnia Drug Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Hypersomnia Drug Business (2016-2021)
Figure 64. Theranexus Revenue Growth Rate in Hypersomnia Drug Business (2016-2021)
Figure 65. Fisher & Paykel Healthcare Revenue Growth Rate in Hypersomnia Drug Business (2016-2021)
Figure 66. Drive Medical Revenue Growth Rate in Hypersomnia Drug Business (2016-2021)
Figure 67. Merck Revenue Growth Rate in Hypersomnia Drug Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の喉頭蓋炎治療薬市場規模・現状・予測（2021年-2027年） Epiglottitis is a bacterial viral infection which results in inflammation and swelling of epiglottis, basically epiglottis is a cartilage structure which located at the back of the throat, beneath the tongue and the function of epiglottis is close over the trachea when foods are being swallowed, Epi…- 世界の睡眠運動障害治療薬市場規模・現状・予測（2021年-2027年） Sleep movement disorders are the disorders disrupting during sleep and generally have undesirable verbal or physical behaviors which frequently result in insomnia and daytime fatigue. Movements during sleep are very common, especially among children. Market Analysis and Insights: Global Sleep Moveme…
- 世界の記憶力増強薬市場規模・現状・予測（2021年-2027年） Memory-enhancing drugs are used for the treatment of diminished or decreased ability of person to memories due to traumatic injury to the central nervous system (CNS) or due to aging. The start of the memory loss or decreased cognition may result into the onset of the Alzheimer’s disease. Market Ana…
- 世界の心臓代謝薬市場規模・現状・予測（2021年-2027年） Cardiometabolic drugs are purposefully used for a vast composition of metabolic dysfunction, disorders include impaired glucose tolerance, insulin resistance, hypertension, dyslipidemia, and central adiposity. Market Analysis and Insights: Global Cardiometabolic Drug Market The global Cardiometaboli…
- 世界の橋本甲状腺炎治療薬市場規模・現状・予測（2021年-2027年） Hashimoto's thyroiditis one of the most prevalent and common autoimmune disease. The individual suffering from Hashimoto’s thyroiditis has his/her own immune system attack the thyroid gland leading to chronic destruction of the thyroid gland. This causes inflammation and reduces the secretion of thy…